02754nam 2200553Ia 450 991078686210332120200520144314.01-62100-491-0(CKB)2670000000370488(EBL)3022365(SSID)ssj0000886171(PQKBManifestationID)11464527(PQKBTitleCode)TC0000886171(PQKBWorkID)10818018(PQKB)10630455(MiAaPQ)EBC3022365(Au-PeEL)EBL3022365(CaPaEBR)ebr10704556(OCoLC)849920834(EXLCZ)99267000000037048820111102d2012 uy 0engur|n|---|||||txtccrHeparin[electronic resource] properties, uses and side effects /David E. Piyathilake and Rhong Liang, editorsHauppauge, NY Nova Science Publisher'sc20121 online resource (346 p.)Pharmacology - research, safety testing and regulationDescription based upon print version of record.1-62100-431-7 Includes bibliographical references and index.The pharmacology of oral heparins -- Suppression of membrane vesiculation : a possible anticoagulant, Antimetastatic and anti-inflammatory effect of heparin -- Beyond anticoagulation : roles for heparin in the vasculature -- Heparin monitoring : from blood tube to microfluidic device -- Advances in the analysis of the heparins -- Searching for heparin binding partners -- Heparin-related nanomaterials -- Pharmacokinetic differences among unfractionated heparin and low molecular weight heparins : impact in patients with renal impairment -- Comprehensive and updated study on the analysis techniques of heparin for human use -- The elaboration of new blood plasma anticoagulant complexes of high-molecular-weight heparin with glyproline peptides main amino acids on the base of mathematical simulation of pH- metry data -- Application of chemometric techniques to heparin purity analysis and quality control using proton NMR spectral data -- Heparin : the side effect of heparin, particularly, heparin induced thrombocytopenia.Pharmacology - Research, Safety Testing and Regulation Biochemistry Research TrendsHeparinAnticoagulants (Medicine)Heparin.Anticoagulants (Medicine)615.7/18Piyathilake David E1513005Liang Rhong1513006MiAaPQMiAaPQMiAaPQBOOK9910786862103321Heparin3747244UNINA